Flexible, Modern Facilities
Northway Biotech operates two state-of-the-art facilities in Vilnius, Lithuania, designed to support the development and manufacturing of protein-based biologics and gene therapies.
Our biologics facility includes more than 40 advanced R&D laboratories for cell line development, upstream/downstream process development, and analytical services, alongside cGMP manufacturing suites equipped with both single-use and stainless steel systems. This site supports microbial and mammalian expression platforms and offers full drug substance production as well as aseptic fill-finish capabilities.
In 2024, we expanded our footprint with the opening of the Baltics’ first dedicated gene therapy manufacturing center - an 8,000 m² facility purpose-built for cGMP production of viral vectors and plasmid DNA. This site delivers end-to-end gene therapy CDMO services, including vector production, cell banking, and viral clearance studies.
Together, these two facilities form a robust, flexible, and scalable infrastructure for clients seeking high-quality, integrated biologics and gene therapy manufacturing solutions in the heart of Europe.